vs
ICU MEDICAL INC（ICUI）与OUTFRONT Media Inc.（OUT）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是OUTFRONT Media Inc.的1.1倍（$540.7M vs $513.3M），OUTFRONT Media Inc.净利率更高（18.9% vs -2.9%，领先21.8%），OUTFRONT Media Inc.同比增速更快（4.1% vs -14.1%），OUTFRONT Media Inc.自由现金流更多（$93.3M vs $36.0M），过去两年OUTFRONT Media Inc.的营收复合增速更高（12.1% vs -2.3%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
OUTFRONT Media Inc.是一家美国广告企业，业务覆盖美国本土，由首席执行官Nick Brien领导美洲区业务，核心经营广告牌及公共交通展示广告两大业务板块，是户外广告领域的重要参与者。
ICUI vs OUT — 直观对比
营收规模更大
ICUI
是对方的1.1倍
$513.3M
营收增速更快
OUT
高出18.2%
-14.1%
净利率更高
OUT
高出21.8%
-2.9%
自由现金流更多
OUT
多$57.3M
$36.0M
两年增速更快
OUT
近两年复合增速
-2.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $513.3M |
| 净利润 | $-15.7M | $96.8M |
| 毛利率 | 37.5% | — |
| 营业利润率 | 1.0% | 26.0% |
| 净利率 | -2.9% | 18.9% |
| 营收同比 | -14.1% | 4.1% |
| 净利润同比 | 34.0% | 30.8% |
| 每股收益（稀释后） | $-0.63 | $0.57 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICUIOUT
| Q4 25 | $540.7M | $513.3M | ||
| Q3 25 | $537.0M | $467.5M | ||
| Q2 25 | $548.9M | $460.2M | ||
| Q1 25 | $604.7M | $390.7M | ||
| Q4 24 | $629.8M | $493.2M | ||
| Q3 24 | $589.1M | $451.9M | ||
| Q2 24 | $596.5M | $477.3M | ||
| Q1 24 | $566.7M | $408.5M |
净利润ICUIOUT
| Q4 25 | $-15.7M | $96.8M | ||
| Q3 25 | $-3.4M | $51.3M | ||
| Q2 25 | $35.3M | $19.5M | ||
| Q1 25 | $-15.5M | $-20.6M | ||
| Q4 24 | $-23.8M | $74.0M | ||
| Q3 24 | $-33.0M | $34.6M | ||
| Q2 24 | $-21.4M | $176.8M | ||
| Q1 24 | $-39.5M | $-27.2M |
毛利率ICUIOUT
| Q4 25 | 37.5% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 37.9% | — | ||
| Q1 25 | 34.7% | — | ||
| Q4 24 | 36.1% | — | ||
| Q3 24 | 34.8% | — | ||
| Q2 24 | 34.8% | — | ||
| Q1 24 | 32.7% | — |
营业利润率ICUIOUT
| Q4 25 | 1.0% | 26.0% | ||
| Q3 25 | 2.6% | 19.2% | ||
| Q2 25 | 1.9% | 12.2% | ||
| Q1 25 | 2.1% | 3.6% | ||
| Q4 24 | 6.0% | 22.5% | ||
| Q3 24 | 1.4% | 15.8% | ||
| Q2 24 | 1.3% | 48.0% | ||
| Q1 24 | -1.9% | 3.4% |
净利率ICUIOUT
| Q4 25 | -2.9% | 18.9% | ||
| Q3 25 | -0.6% | 11.0% | ||
| Q2 25 | 6.4% | 4.2% | ||
| Q1 25 | -2.6% | -5.3% | ||
| Q4 24 | -3.8% | 15.0% | ||
| Q3 24 | -5.6% | 7.7% | ||
| Q2 24 | -3.6% | 37.0% | ||
| Q1 24 | -7.0% | -6.7% |
每股收益（稀释后）ICUIOUT
| Q4 25 | $-0.63 | $0.57 | ||
| Q3 25 | $-0.14 | $0.29 | ||
| Q2 25 | $1.43 | $0.10 | ||
| Q1 25 | $-0.63 | $-0.14 | ||
| Q4 24 | $-0.97 | $0.49 | ||
| Q3 24 | $-1.35 | $0.19 | ||
| Q2 24 | $-0.88 | $1.01 | ||
| Q1 24 | $-1.63 | $-0.18 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $99.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.1B | $710.4M |
| 总资产 | $4.1B | $5.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ICUIOUT
| Q4 25 | — | $99.9M | ||
| Q3 25 | — | $63.0M | ||
| Q2 25 | — | $28.5M | ||
| Q1 25 | — | $30.5M | ||
| Q4 24 | $308.6M | $46.9M | ||
| Q3 24 | $312.5M | $28.0M | ||
| Q2 24 | $302.6M | $49.6M | ||
| Q1 24 | $251.4M | $42.4M |
股东权益ICUIOUT
| Q4 25 | $2.1B | $710.4M | ||
| Q3 25 | $2.1B | $542.6M | ||
| Q2 25 | $2.1B | $539.1M | ||
| Q1 25 | $2.0B | $566.9M | ||
| Q4 24 | $2.0B | $649.0M | ||
| Q3 24 | $2.0B | $618.2M | ||
| Q2 24 | $2.0B | $664.9M | ||
| Q1 24 | $2.1B | $524.2M |
总资产ICUIOUT
| Q4 25 | $4.1B | $5.3B | ||
| Q3 25 | $4.1B | $5.2B | ||
| Q2 25 | $4.1B | $5.1B | ||
| Q1 25 | $4.2B | $5.1B | ||
| Q4 24 | $4.2B | $5.2B | ||
| Q3 24 | $4.3B | $5.2B | ||
| Q2 24 | $4.3B | $5.3B | ||
| Q1 24 | $4.3B | $5.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $118.1M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $93.3M |
| 自由现金流率自由现金流/营收 | 6.6% | 18.2% |
| 资本支出强度资本支出/营收 | 4.6% | 4.8% |
| 现金转化率经营现金流/净利润 | — | 1.22× |
| 过去12个月自由现金流最近4个季度 | $91.8M | $218.8M |
8季度趋势，按日历期对齐
经营现金流ICUIOUT
| Q4 25 | $60.6M | $118.1M | ||
| Q3 25 | $56.7M | $88.8M | ||
| Q2 25 | $11.2M | $67.1M | ||
| Q1 25 | $51.3M | $33.6M | ||
| Q4 24 | $40.2M | $124.5M | ||
| Q3 24 | $36.1M | $73.1M | ||
| Q2 24 | $82.0M | $71.0M | ||
| Q1 24 | $45.8M | $30.6M |
自由现金流ICUIOUT
| Q4 25 | $36.0M | $93.3M | ||
| Q3 25 | $27.6M | $67.7M | ||
| Q2 25 | $-8.5M | $41.4M | ||
| Q1 25 | $36.7M | $16.4M | ||
| Q4 24 | $16.1M | $106.3M | ||
| Q3 24 | $16.2M | $55.5M | ||
| Q2 24 | $62.5M | $47.1M | ||
| Q1 24 | $29.9M | $12.2M |
自由现金流率ICUIOUT
| Q4 25 | 6.6% | 18.2% | ||
| Q3 25 | 5.1% | 14.5% | ||
| Q2 25 | -1.5% | 9.0% | ||
| Q1 25 | 6.1% | 4.2% | ||
| Q4 24 | 2.6% | 21.6% | ||
| Q3 24 | 2.7% | 12.3% | ||
| Q2 24 | 10.5% | 9.9% | ||
| Q1 24 | 5.3% | 3.0% |
资本支出强度ICUIOUT
| Q4 25 | 4.6% | 4.8% | ||
| Q3 25 | 5.4% | 4.5% | ||
| Q2 25 | 3.6% | 5.6% | ||
| Q1 25 | 2.4% | 4.4% | ||
| Q4 24 | 3.8% | 3.7% | ||
| Q3 24 | 3.4% | 3.9% | ||
| Q2 24 | 3.3% | 5.0% | ||
| Q1 24 | 2.8% | 4.5% |
现金转化率ICUIOUT
| Q4 25 | — | 1.22× | ||
| Q3 25 | — | 1.73× | ||
| Q2 25 | 0.32× | 3.44× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.68× | ||
| Q3 24 | — | 2.11× | ||
| Q2 24 | — | 0.40× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
OUT
| Static Displays | $236.3M | 46% |
| Other | $134.8M | 26% |
| Digital Displays | $125.3M | 24% |
| Other Revenues | $1.9M | 0% |
